November will be an exciting time for the U.S. cannabis industry, as there is a possibility of three states legalizing adult-use cannabis. This week, the North Dakota's Secretary of State has announced that they will have a chance at legalizing adult-use cannabis as enough valid voter signatures were collected to put the measure on November's ballot. Two more states are up for the legalization vote: Florida and South Dakota.
Like North Dakota, South Dakota also gets its third try at legalization, needing a majority of voters in favor. In Florida, the legalization amendment needs a 60% majority to pass. A recent survey showed promising results, with 64% supporting the legalization in Florida.
North Dakota
For North Dakota, over 22,000 voter signatures were submitted, according to New Economic Frontier. At least 15,582 valid signatures were required to qualify the proposal and officials validated 18,964 signatures.
Under the new legalization measure, adults 21 years and older would be able to have up to one ounce of cannabis flower, four grams of concentrate and 300 milligrams of edibles that they could purchase from a limited number of licensed dispensaries. Adults would also be allowed to grow up to three plants for personal use with a six-plant limit on each household.
Third time's a charm?
"The North Dakota 2024 ballot will provide its voters with a third opportunity to legalize the adult-use of cannabis in its state after voters rejected similar measures in 2018 and 2022," says Paula Savchenko, Founding Partner of Cannacore Group and PS Law Group. "Many are hopeful that 'third time's a charm' in this election and that the majority of voters will approve of the statutory measure, which includes home cultivation. Due to its prior rejections, it is now vital the pro-legalization campaign emphasizes the measure's potential for increasing economic growth and job development, as well as reducing the burden on law enforcement to allow them to more effectively allocate their resources to other crises, such as the fentanyl and opioid epidemics."
For more information:
Cannacore Group
https://www.cannacoregrp.com/